BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1676 related articles for article (PubMed ID: 27235851)

  • 1. Keeping the senescence secretome under control: Molecular reins on the senescence-associated secretory phenotype.
    Malaquin N; Martinez A; Rodier F
    Exp Gerontol; 2016 Sep; 82():39-49. PubMed ID: 27235851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-canonical ATM/MRN activities temporally define the senescence secretory program.
    Malaquin N; Olivier MA; Martinez A; Nadeau S; Sawchyn C; Coppé JP; Cardin G; Mallette FA; Campisi J; Rodier F
    EMBO Rep; 2020 Oct; 21(10):e50718. PubMed ID: 32785991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype.
    Freund A; Patil CK; Campisi J
    EMBO J; 2011 Apr; 30(8):1536-48. PubMed ID: 21399611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying Senescence-Associated Phenotypes in Primary Multipotent Mesenchymal Stromal Cell Cultures.
    Nadeau S; Cheng A; Colmegna I; Rodier F
    Methods Mol Biol; 2019; 2045():93-105. PubMed ID: 31020633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The senescence-associated secretory phenotype and its regulation.
    Lopes-Paciencia S; Saint-Germain E; Rowell MC; Ruiz AF; Kalegari P; Ferbeyre G
    Cytokine; 2019 May; 117():15-22. PubMed ID: 30776684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing Functional Roles of the Senescence-Associated Secretory Phenotype (SASP).
    Malaquin N; Tu V; Rodier F
    Methods Mol Biol; 2019; 1896():45-55. PubMed ID: 30474839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Regulators of the Senescence-Associated Secretory Phenotype During Senescence and Aging.
    Han X; Lei Q; Xie J; Liu H; Li J; Zhang X; Zhang T; Gou X
    J Gerontol A Biol Sci Med Sci; 2022 Nov; 77(11):2207-2218. PubMed ID: 35524726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insight into the role of PIKK family members and NF-кB in DNAdamage-induced senescence and senescence-associated secretory phenotype of colon cancer cells.
    Strzeszewska A; Alster O; Mosieniak G; Ciolko A; Sikora E
    Cell Death Dis; 2018 Jan; 9(2):44. PubMed ID: 29352261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic and scalable assessment of the senescence-associated secretory phenotype (SASP).
    Malaquin N; Rodier F
    Methods Cell Biol; 2024; 181():181-195. PubMed ID: 38302239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MLL1 is essential for the senescence-associated secretory phenotype.
    Capell BC; Drake AM; Zhu J; Shah PP; Dou Z; Dorsey J; Simola DF; Donahue G; Sammons M; Rai TS; Natale C; Ridky TW; Adams PD; Berger SL
    Genes Dev; 2016 Feb; 30(3):321-36. PubMed ID: 26833731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Senescence-Associated Secretory Phenotype: Critical Effector in Skin Cancer and Aging.
    Ghosh K; Capell BC
    J Invest Dermatol; 2016 Nov; 136(11):2133-2139. PubMed ID: 27543988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Senescence and the SASP: many therapeutic avenues.
    Birch J; Gil J
    Genes Dev; 2020 Dec; 34(23-24):1565-1576. PubMed ID: 33262144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging role of NF-κB signaling in the induction of senescence-associated secretory phenotype (SASP).
    Salminen A; Kauppinen A; Kaarniranta K
    Cell Signal; 2012 Apr; 24(4):835-45. PubMed ID: 22182507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4.
    Kang C; Xu Q; Martin TD; Li MZ; Demaria M; Aron L; Lu T; Yankner BA; Campisi J; Elledge SJ
    Science; 2015 Sep; 349(6255):aaa5612. PubMed ID: 26404840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleiotropic effects of BAFF on the senescence-associated secretome and growth arrest.
    Rossi M; Anerillas C; Idda ML; Munk R; Shin CH; Donega S; Tsitsipatis D; Herman AB; Martindale JL; Yang X; Piao Y; Mazan-Mamczarz K; Fan J; Ferrucci L; Johnson PF; De S; Abdelmohsen K; Gorospe M
    Elife; 2023 Apr; 12():. PubMed ID: 37083495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism.
    Wang R; Yu Z; Sunchu B; Shoaf J; Dang I; Zhao S; Caples K; Bradley L; Beaver LM; Ho E; Löhr CV; Perez VI
    Aging Cell; 2017 Jun; 16(3):564-574. PubMed ID: 28371119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unmasking Transcriptional Heterogeneity in Senescent Cells.
    Hernandez-Segura A; de Jong TV; Melov S; Guryev V; Campisi J; Demaria M
    Curr Biol; 2017 Sep; 27(17):2652-2660.e4. PubMed ID: 28844647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Punicalagin induces senescent growth arrest in human papillary thyroid carcinoma BCPAP cells via NF-κB signaling pathway.
    Cheng X; Yao X; Xu S; Pan J; Yu H; Bao J; Guan H; Lu R; Zhang L
    Biomed Pharmacother; 2018 Jul; 103():490-498. PubMed ID: 29677534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-κB-dependent secretome of senescent cells can trigger neuroendocrine transdifferentiation of breast cancer cells.
    Raynard C; Ma X; Huna A; Tessier N; Massemin A; Zhu K; Flaman JM; Moulin F; Goehrig D; Medard JJ; Vindrieux D; Treilleux I; Hernandez-Vargas H; Ducreux S; Martin N; Bernard D
    Aging Cell; 2022 Jul; 21(7):e13632. PubMed ID: 35653631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Aspects of Senescence and Organismal Ageing-DNA Damage Response, Telomeres, Inflammation and Chromatin.
    Sławińska N; Krupa R
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 84.